Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions
Clinical trial NCT01282801 · COMPLETED
Trial details
- NCT number
- NCT01282801
- Sponsor
- Teva Pharmaceuticals USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Primary completion
- 2002-10-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.